Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06408779
NCT06408779
Completed
Not Applicable

Study on Surgical Treatment Strategies for Moderate Ischemic Mitral Regurgitation

China National Center for Cardiovascular Diseases1 site in 1 country464 target enrollmentAugust 1, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMitral Valve InsufficiencyMitral Valve AnnuloplastyCoronary Artery Bypass

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mitral Valve Insufficiency
Sponsor
China National Center for Cardiovascular Diseases
Enrollment
464
Locations
1
Primary Endpoint
major adverse cardiovascular and cerebrovascular events
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This study aimed to compare the efficacy of isolated coronary artery bypass grafting and coronary artery bypass grafting + mitral valve repair in moderate ischemic mitral regurgitation patients through a cohort and explore the potential risk factors of the clinical outcomes.

Registry
clinicaltrials.gov
Start Date
August 1, 2023
End Date
April 1, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
China National Center for Cardiovascular Diseases
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Adult coronary artery disease patients complicated with moderate ischemic mitral regurgitation.
  • •undergoing coronary artery bypass grafting with or without mitral valve repair.

Exclusion Criteria

  • •patients under the age of 18 years,
  • •patients complicated with more than moderate ischemic mitral regurgitation or undergoing mitral valve replacement,
  • •patients complicated with primary mitral valve disease other than ischemic mitral regurgitation, such as rheumatic mitral regurgitation or mitral valve leaflet prolapse,
  • •patients undergoing concomitant aortic valve procedure.

Outcomes

Primary Outcomes

major adverse cardiovascular and cerebrovascular events

Time Frame: 2years

the composite of all-cause death, rehospitalization for heart failure, non-fatal myocardial infarction, non-fatal stroke or repeat mitral valve surgery.

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Phase 2
Surgical Manipulation of the Aorta and Cerebral InfarctionCoronary Heart DiseaseStrokeCerebral Infarction
NCT00558779University of Wuerzburg200
Completed
Not Applicable
Long-term Comparison of Stenting Versus Off-pump Coronary Bypass SurgeryCoronary Artery Disease
NCT00975858UMC Utrecht280
Completed
Not Applicable
Two Surgical Approaches for Root Coverage of Teeth Presenting Gingival Recession and Non-carious Cervical LesionGingival Recession
NCT03341598Universidade Estadual Paulista Júlio de Mesquita Filho60
Completed
Not Applicable
Coronary Revascularization Outcomes Within Necessary Sex and Gender AspectsCoronary Artery DiseaseIschemic Heart DiseaseCoronary Artery Bypass Grafting
NCT06749171Federal State Budgetary Institution "Federal Center for Cardiovascular Surgery named after S.G. Sukh400
Terminated
Phase 3
Assessment of Revascularization Versus Conservative Treatment in Heart Transplant Patients for a Clinical Event ReductionHeart-lung Transplant Rejection
NCT01795729Assistance Publique - Hôpitaux de Paris6